Drug recall · May 10, 2017
Aripiprazole Tablets recall
Why: Superpotent Drug; out of specification results for assay (manufacturer)
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Aripiprazole Tablets, 2 mg, 30 count unit dose box, Rx only, Manufactured by Apotex Inc., Toronto, Ontario, Canada, Distributed by Major Pharmaceuticals, Livonia, MI NDC 0904-6509-04
- Lots / codes
LOT: T-00601 Exp: 04-2017
- Quantity
- 36,990 tablets
- Company
- The Harvard Drug Group, Livonia, MI
- Distribution
- Nationwide and PR
- Initiated
- December 27, 2016 · Voluntary: Firm initiated
- Classified
- May 2, 2017
- Reported
- May 10, 2017
- Ended
- July 27, 2017
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Aripiprazole
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.